Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other Accumulated Expenses: 2015-2024

Historic Other Accumulated Expenses for CorMedix (CRMD) over the last 9 years, with Dec 2024 value amounting to $122,357.

  • CorMedix's Other Accumulated Expenses rose 45.15% to $278,684 in Q3 2025 from the same period last year, while for Sep 2025 it was $278,684, marking a year-over-year increase of 45.15%. This contributed to the annual value of $122,357 for FY2024, which is N/A change from last year.
  • CorMedix's Other Accumulated Expenses amounted to $122,357 in FY2024, which was up 89.83% from $64,456 recorded in FY2022.
  • In the past 5 years, CorMedix's Other Accumulated Expenses ranged from a high of $144,001 in FY2020 and a low of $64,456 during FY2022.
  • Moreover, its 2-year median value for Other Accumulated Expenses was $93,406 (2022), whereas its average is $93,406.
  • In the last 5 years, CorMedix's Other Accumulated Expenses skyrocketed by 163.42% in 2020 and then slumped by 34.21% in 2021.
  • CorMedix's Other Accumulated Expenses (Yearly) stood at $144,001 in 2020, then tumbled by 34.21% to $94,736 in 2021, then crashed by 31.96% to $64,456 in 2022, then reached $122,357 in 2024.